Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Directorate Change

23 Nov 2023 10:00

RNS Number : 4621U
Phoenix Group Holdings PLC
23 November 2023

LEI: 2138001P49OLAEU33T68

23 November 2023

Phoenix Group Holdings plc - Board Changes

The Phoenix Group Holdings plc Board is pleased to announce that Eleanor Bucks will be appointed as an independent Non-Executive Director with effect from 1 December 2023.

Eleanor is currently Chief Investment Officer of Lloyd's of London where she has gained strong corporate governance experience as a member of the Lloyds Investment Committee, a Council of Lloyd's sub-committee, while responsible for the investment management of c.£14bn in assets globally, and investment oversight and leadership for the c.£95bn of assets within the Lloyd's market and capital setting for market risk.

She previously spent 15 years at Legal & General in increasingly senior and varied roles, whilst also developing her governance skillset as a member of the divisional Executive Committee, Investment Committee, Chair of the divisional Sustainability Committee, and Chair of the divisional Direct Investment Committee. In the context of life assurance, her experience includes investment management, risk management, customer solutions and operations. She is a proven leader who has a deep understanding of sustainable assets and ESG, and the development of alternative retirement products.

Commenting on the appointment, Alastair Barbour, Chair of Phoenix Group said:

"We are delighted that Eleanor has agreed to join the Board of Phoenix Group Holdings plc. She is an accomplished Actuary and Chief Investment Officer demonstrating strong financial services, insurance and stakeholder management experience. She brings fresh capability and skills together with a deep understanding of both our business and markets and will be a positive resource as Phoenix pursues its long-term strategy."

There is no further information required to be notified under Listing Rule 9.6.13 R with regard to Eleanor Bucks's appointment referred to above.

Enquiries:

Media Douglas Campbell

Teneo

+44 (0)7753 136628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0) 204 559 3031

Investors Claire Hawkins, Corporate Affairs Director, Phoenix Group +44 (0) 204 559 3161

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0) 204 559 3145

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOAKZMZMRFFGFZG
Date   Source Headline
24th Feb 20262:25 pmRNSChange of Company Name
18th Feb 20262:12 pmRNSAppointment of Corporate Broker
6th Feb 20261:52 pmRNSDirector/PDMR Shareholding
2nd Feb 202611:02 amRNSTotal Voting Rights
6th Jan 20261:31 pmRNSDirector/PDMR Shareholding
2nd Jan 202611:06 amRNSTotal Voting Rights
18th Dec 20252:38 pmRNSCompletion of Redemption at Maturity
18th Dec 20252:38 pmRNSCompletion of Redemption at Maturity
12th Dec 20252:49 pmRNSBlock listing Return
8th Dec 202511:08 amRNSDirector/PDMR Shareholding
1st Dec 20251:57 pmRNSTotal Voting Rights
24th Nov 20255:20 pmRNSBlock Listing Application
24th Nov 20257:09 amRNSLIST 2025 Results Show Robust Capital Position
6th Nov 20253:47 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:01 pmRNSTotal Voting Rights
31st Oct 20253:10 pmRNSDirector/PDMR Shareholding
7th Oct 20251:20 pmRNSDirector/PDMR Shareholding
1st Oct 202512:38 pmRNSTotal Voting Rights
17th Sep 20252:40 pmRNSPublication of a Supplementary Prospectus
10th Sep 20252:51 pmRNSDirector/PDMR Shareholding
8th Sep 20255:23 pmRNSDirector/PDMR Shareholding
8th Sep 20257:00 amRNS2025 Interim Results
1st Sep 202510:00 amRNSTotal Voting Rights
18th Aug 202510:00 amRNSBoard Changes
6th Aug 202512:53 pmRNSDirector/PDMR Shareholding
1st Aug 202510:18 amRNSTotal Voting Rights
8th Jul 20253:31 pmRNSDirector/PDMR Shareholding
1st Jul 202512:26 pmRNSTotal Voting Rights
26th Jun 20259:00 amRNSBoard Changes
13th Jun 20253:00 pmRNSPublication of Prospectus
12th Jun 20252:43 pmRNSBlock listing Return
9th Jun 202512:25 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:44 pmRNSTotal Voting Rights
23rd May 20253:02 pmRNSDirector/PDMR Shareholding
20th May 202510:00 amRNSDirector Declaration
13th May 20253:34 pmRNSResult of AGM
7th May 20254:20 pmRNSDirector/PDMR Shareholding
1st May 202510:33 amRNSTotal Voting Rights
10th Apr 20252:37 pmRNSDirector/PDMR Shareholding
8th Apr 20253:10 pmRNSDirector/PDMR Shareholding
3rd Apr 20251:35 pmRNSNotice of AGM
1st Apr 20252:52 pmRNSDirector/PDMR Shareholding
1st Apr 20252:42 pmRNSTotal Voting Rights
26th Mar 20253:46 pmRNSDirector/PDMR Shareholding
24th Mar 20255:43 pmRNSDirector/PDMR Shareholding
21st Mar 202511:56 amRNSDirector/PDMR Shareholding
20th Mar 20254:19 pmRNSDirector/PDMR Shareholding
19th Mar 20254:26 pmRNSDirector/PDMR Shareholding
19th Mar 20252:15 pmRNSDirector/PDMR Shareholding
17th Mar 20257:00 amRNS2024 Annual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.